#Canada #Toronto #AI in Healthcare #Clinical Trials #Xtalks Webinar

Revolutionizing Clinical Trials: The Impact of AI on Design and Protocol Amendments

As the intersection of artificial intelligence (AI) and healthcare continues to evolve, it is paramount for clinical trial professionals to understand how these advancements can streamline processes and enhance outcomes. On May 28, 2026, Xtalks will host a free webinar titled "From Amendments to Optimization: How AI is Transforming Clinical Trial Design," aimed at addressing critical challenges in clinical trial protocols related to eligibility requirements and design amendments.

The Cost of Protocol Amendments

Research indicates that a staggering 57% of clinical trial protocols experience at least one significant amendment, with a notable 45% of those being avoidable (Getz et al., 2016). These changes are not just administrative inconveniences; they can lead to frozen enrollment periods, pushing timelines back by several weeks and costing over $535,000 in direct expenses. The webinar will delve into these financial implications and address how early identification of amendment risks can mitigate such costs.

Identifying Amendment Risks

One of the primary focuses of the session will be to explore the eligibility criteria that frequently necessitate amendments. The experienced speakers will unpack site selection factors that predict enrollment performance, emphasizing a data-driven approach to uncover patterns and risks that may lurk in large trial datasets. By leveraging AI, trial teams can identify red flags far earlier in the process, enabling timely adjustments that enhance overall study efficiency and effectiveness.

Expertise from Industry Leaders

Featured speakers for the webinar include:

• - Paolo Martini, Chief Research and Development Officer
• - Pedro Coelho, Founder and CEO of Biorce
• - Bruno Gagnon, BPharm, MSc, Senior Vice President of Clinical Development Operations at Spruce Biosciences

Each speaker brings a wealth of knowledge about the intricacies of clinical trials and will provide practical insights on applying AI-supported solutions to improve trial designs and regulatory outcomes. Attendees will gain valuable strategies to defend AI-integrated decisions in front of regulatory bodies, ensuring compliance with EMA and FDA requirements.

The Benefits of AI Assistance

AI technology holds immense potential not only for reducing the number of protocol amendments but also for enabling more robust planning for patient enrollments across diverse therapeutic areas. The collaborative insights will also focus on how to tailor design decisions effectively, promoting defensibility in regulatory reviews. Participants can expect to leave with actionable recommendations that address common hurdles in clinical trial planning.

How to Register

Don't miss this opportunity to enhance your understanding of AI's transformative role in clinical trials. To register for the live webinar, visit Xtalks. Join industry peers as they navigate the future intersection of artificial intelligence and clinical trial design, ensuring that your organization remains at the forefront of these essential developments.

As a seasoned professional in the life sciences arena, being part of this webinar will not only equip you with the knowledge to optimize your clinical trials but also align your strategic goals with the technological advancements shaping the future of medicine.

Whether you are a clinical trial manager, a regulatory professional, or simply interested in the evolving landscape of clinical research, this session promises to enrich your expertise while potentially saving your organization significant costs and time in the trial development process.